Abstract
Purpose
The purpose was to establish a mild ovarian stimulation protocol that would help assisted reproductive technology (ART) units to avoid scheduling on weekends.
Methods
This protocol directed patients to take 50 mg/day of clomiphene citrate between days 3 and 7 of the menstrual cycle: 225 IU of recombinant follicle-stimulating hormone (rec-FSH) were administered on days 3, 5 and 7; human chorionic gonadotropin (hCG) was administered on day 9; and, oocyte pick-up (OPU) was planned for day 11. From October 2008 through October 2009, 514 women underwent ART treatment with mild stimulation at the Sugiyama Clinic, and we evaluated whether OPU was accomplished on the planned day.
Results
Of all the treatment cycles, 419 (81.5%) underwent OPU on day 11 (scheduled group). Additional rec-FSH administration was needed in 83 cycles, in which case OPU was performed on day 12 or later. In 12 cycles, OPU was canceled. The unscheduled group (n = 95) consisted of delayed OPU cycles and canceled cycles. Of all treatment cycles, 332 cycles in the scheduled group and 68 cycles in the unscheduled group underwent embryo transfer, with 81 and 16, respectively, resulting in pregnancies.
Conclusions
Using this protocol, OPU was performed on the scheduled day in about 80% of the cycles. Most weekend scheduling of OPU can be avoided using this mild stimulation.
Similar content being viewed by others
References
Poter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in vitro fertilization using buserelin and gonadotrophins. Lancet. 1984;2:1284–5.
Fauser BC, Devroy P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet. 2005;365:1807–16.
Macklon NS, Ctouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170–207.
Nakagawa K, Yamano S, Senuma M, Myogo K, Yamazaki J, Aono T. Avoidance of oocyte retrieval on the weekend thorough the use of scheduled ovarian hyperstimulation for in vitro fertilization and embryo transfer. Fertil Steril. 1997;68:787–90.
Nakagawa K, Ohgi S, Kojima R, Ito M, Horikawa T, Irahara M, Saito H. Reduction of perifollicular arterial blood flow resistance after hCG administration is a good indicator of the recovery of mature oocytes in ART treatment. J Assist Reprod Genet. 2006;23:433–8.
Nakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M, Aono T. Effect of activation with Ca ionophore A23187 and puromycin on the development of human oocytes that failed to fertilize after intracytoplasmic sperm injection. Fertil Steril. 2001;76:148–52.
Sugiyama R, Nakagawa K, Shirai A, Sugiyama R, Nishi Y, Kuribayashi Y, Inoue M. Clinical outcomes resulting from the transfer of vitrified human embryos using a new device for cryopreservation (plastic blade). J Assist Reprod Genet. 2010;27:161–7.
Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin-releasing antagonists for assisted conception: a Cochran review. Reprod Biomed Online. 2007;14:640–9.
Kojima R, Nakagawa K, Nakashima A, Horikawa T, Ohgi S, Saito H. Elevated basal FSH levels, if it is under 15 IU/L, will not reflect poor ART outcomes. J Assist Reprod Genet. 2008;25:73–7.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Nakagawa, K., Nishi, Y., Sugiyama, R. et al. A programmed schedule of oocyte retrieval using mild ovarian stimulation (clomiphene citrate and recombinant follicle-stimulating hormone). Reprod Med Biol 11, 85–89 (2012). https://doi.org/10.1007/s12522-011-0110-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12522-011-0110-9